LANVIS 40 MG COMPRIMIDOS
LANVIS 40 MG COMPRIMIDOS
Commercialized
Register Number
84019
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
Mar 10, 2021
Dosage Form
COMPRIMIDO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number84019
EMA Approved
No
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
TIOGUANINAActive
Quantity: 40 mg
Name: TIOGUANINA
ATC CLASSIFICATION (3)
L01B
L01BB
L01BB03